1081 related articles for article (PubMed ID: 29174803)
21. Oncoprotein HBXIP induces PKM2 via transcription factor E2F1 to promote cell proliferation in ER-positive breast cancer.
Liu BW; Wang TJ; Li LL; Zhang L; Liu YX; Feng JY; Wu Y; Xu FF; Zhang QS; Bao MZ; Zhang WY; Ye LH
Acta Pharmacol Sin; 2019 Apr; 40(4):530-538. PubMed ID: 29925919
[TBL] [Abstract][Full Text] [Related]
22. HBXIP up-regulates ACSL1 through activating transcriptional factor Sp1 in breast cancer.
Wang Y; Cai X; Zhang S; Cui M; Liu F; Sun B; Zhang W; Zhang X; Ye L
Biochem Biophys Res Commun; 2017 Mar; 484(3):565-571. PubMed ID: 28132807
[TBL] [Abstract][Full Text] [Related]
23. The oncoprotein HBXIP up-regulates FGF4 through activating transcriptional factor Sp1 to promote the migration of breast cancer cells.
Shi H; Li Y; Feng G; Li L; Fang R; Wang Z; Qu J; Ding P; Zhang X; Ye L
Biochem Biophys Res Commun; 2016 Feb; 471(1):89-94. PubMed ID: 26828265
[TBL] [Abstract][Full Text] [Related]
24. The oncoprotein HBXIP upregulates Lin28B via activating TF II D to promote proliferation of breast cancer cells.
Liu Q; Bai X; Li H; Zhang Y; Zhao Y; Zhang X; Ye L
Int J Cancer; 2013 Sep; 133(6):1310-22. PubMed ID: 23494474
[TBL] [Abstract][Full Text] [Related]
25. The oncoprotein HBXIP enhances migration of breast cancer cells through increasing filopodia formation involving MEKK2/ERK1/2/Capn4 signaling.
Li Y; Zhang Z; Zhou X; Li L; Liu Q; Wang Z; Bai X; Zhao Y; Shi H; Zhang X; Ye L
Cancer Lett; 2014 Dec; 355(2):288-96. PubMed ID: 25304384
[TBL] [Abstract][Full Text] [Related]
26. Effect of m6A methyltransferase METTL3 -mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer.
Li S; Jiang F; Chen F; Deng Y; Pan X
J Biochem Mol Toxicol; 2022 Jan; 36(1):e22922. PubMed ID: 34964205
[TBL] [Abstract][Full Text] [Related]
27. HBXIP regulates etoposide-induced cell cycle checkpoints and apoptosis in MCF-7 human breast carcinoma cells.
Fei HR; Li ZJ; Ying-Zhang ; Yue-Liu ; Wang FZ
Gene; 2018 Mar; 647():39-47. PubMed ID: 29309885
[TBL] [Abstract][Full Text] [Related]
28. Oncogenic HBXIP enhances ZEB1 through Sp1 to accelerate breast cancer growth.
Jiang Y; Wang D; Ren H; Shi Y; Gao Y
Thorac Cancer; 2018 Dec; 9(12):1664-1670. PubMed ID: 30273966
[TBL] [Abstract][Full Text] [Related]
29. DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1.
Sun X; Tang SC; Xu C; Wang C; Qin S; Du N; Liu J; Zhang Y; Li X; Luo G; Zhou J; Xu F; Ren H
J Cell Mol Med; 2015 Jun; 19(6):1357-65. PubMed ID: 25702703
[TBL] [Abstract][Full Text] [Related]
30. The oncoprotein hepatitis B X-interacting protein promotes the migration of ovarian cancer cells through the upregulation of S-phase kinase-associated protein 2 by Sp1.
Xu F; Zhu X; Han T; You X; Liu F; Ye L; Zhang X; Wang X; Yao Y
Int J Oncol; 2014 Jul; 45(1):255-63. PubMed ID: 24788380
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory factor TNF-α promotes the growth of breast cancer via the positive feedback loop of TNFR1/NF-κB (and/or p38)/p-STAT3/HBXIP/TNFR1.
Cai X; Cao C; Li J; Chen F; Zhang S; Liu B; Zhang W; Zhang X; Ye L
Oncotarget; 2017 Aug; 8(35):58338-58352. PubMed ID: 28938560
[TBL] [Abstract][Full Text] [Related]
32. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
Tian X; Zhang Z
IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
[TBL] [Abstract][Full Text] [Related]
33. MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m
He H; Wu W; Sun Z; Chai L
Biochem Biophys Res Commun; 2019 Oct; 517(4):581-587. PubMed ID: 31395342
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-107 is downregulated and having tumor suppressive effect in breast cancer by negatively regulating brain-derived neurotrophic factor.
Gao B; Hao S; Tian W; Jiang Y; Zhang S; Guo L; Zhao J; Zhang G; Yan J; Luo D
J Gene Med; 2017 Dec; 19(12):. PubMed ID: 27813254
[TBL] [Abstract][Full Text] [Related]
35. MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein.
Lin L; Liu D; Liang H; Xue L; Su C; Liu M
Int J Clin Exp Pathol; 2015; 8(6):6646-55. PubMed ID: 26261546
[TBL] [Abstract][Full Text] [Related]
36. Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.
Zhou L; Yang C; Zhang N; Zhang X; Zhao T; Yu J
Biomed Pharmacother; 2020 May; 125():109964. PubMed ID: 32044716
[TBL] [Abstract][Full Text] [Related]
37. The oncoprotein HBXIP up-regulates SCG3 through modulating E2F1 and miR-509-3p in hepatoma cells.
Wang Y; Cui M; Cai X; Sun B; Liu F; Zhang X; Ye L
Cancer Lett; 2014 Oct; 352(2):169-78. PubMed ID: 24882622
[TBL] [Abstract][Full Text] [Related]
38. The oncoprotein HBXIP promotes migration of breast cancer cells via GCN5-mediated microtubule acetylation.
Li L; Liu B; Zhang X; Ye L
Biochem Biophys Res Commun; 2015 Mar; 458(3):720-725. PubMed ID: 25686500
[TBL] [Abstract][Full Text] [Related]
39. METTL3-mediated m
Wang Q; Chen C; Ding Q; Zhao Y; Wang Z; Chen J; Jiang Z; Zhang Y; Xu G; Zhang J; Zhou J; Sun B; Zou X; Wang S
Gut; 2020 Jul; 69(7):1193-1205. PubMed ID: 31582403
[TBL] [Abstract][Full Text] [Related]
40. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]